{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05445323",
            "orgStudyIdInfo": {
                "id": "LX2006-01"
            },
            "organization": {
                "fullName": "Lexeo Therapeutics",
                "class": "INDUSTRY"
            },
            "briefTitle": "Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia",
            "officialTitle": "A Phase 1/2 Study of the Safety and Efficacy of LX2006 Gene Therapy in Participants With Cardiomyopathy Associated With Friedreich's Ataxia",
            "therapeuticArea": [
                "Cardiovascular",
                "Other"
            ],
            "study": "gene-therapy-for-cardiomyopathy-associated-with-friedreich-s-ataxia"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-08-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-06-23",
            "studyFirstSubmitQcDate": "2022-06-30",
            "studyFirstPostDateStruct": {
                "date": "2022-07-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Lexeo Therapeutics",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a Phase 1/2, open-label, dose-ascending, multicenter study of the safety and efficacy of LX2006 for participants who have Friedreich's Ataxia with evidence of cardiomyopathy. The study will evaluate up to three doses of single administration of LX2006 (AAVrh.10hFXN), an adeno-associated virus (AAV) gene therapy designed to intravenously deliver the human frataxin (hFXN) gene to cardiac cells over a 52-week period. Long-term safety and efficacy will be evaluated for an additional 4-years for a total of 5-years post LX2006 treatment.",
            "detailedDescription": "Friedreich's ataxia (FA) is a rare, autosomal recessive disease caused by a mutation in the autosomal frataxin (FXN) gene. Progressive cardiomyopathy with cardiac hypertrophy and fibrosis is observed in most individuals with FA. The disease is more severe in those with earlier onset. Presently, there is no therapy that alters the progression of cardiomyopathy in FA, which is responsible for 59% of FA-related deaths.\n\nThe primary objective of this dose escalation study is to assess the safety and tolerability of three ascending doses of LX2006 in patients with FA-associated cardiomyopathy. LX2006 is designed to restore hFXN levels in order to improve mitochondrial function. Assessments of cardiac function, biomarkers and other preliminary efficacy endpoints are also included in this study."
        },
        "conditionsModule": {
            "conditions": [
                "Friedreich Ataxia",
                "Cardiomyopathy, Secondary"
            ],
            "keywords": [
                "Friedreich's Ataxia",
                "Cardiomyopathy",
                "FA",
                "Gene therapy",
                "FXN Gene",
                "Frataxin Gene",
                "LX2006"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 9,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1/ Cohort 2/ Cohort 3",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Genetic: Low dose LX2006",
                        "Genetic: Mid Dose LX2006",
                        "Genetic: High Dose LX2006"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "GENETIC",
                    "name": "Low dose LX2006",
                    "description": "Adeno-associated viral vector encoding the FXN gene (AAVrh.10hFXN)",
                    "armGroupLabels": [
                        "Cohort 1/ Cohort 2/ Cohort 3"
                    ]
                },
                {
                    "type": "GENETIC",
                    "name": "Mid Dose LX2006",
                    "description": "Adeno-associated viral vector encoding the FXN gene (AAVrh.10hFXN)",
                    "armGroupLabels": [
                        "Cohort 1/ Cohort 2/ Cohort 3"
                    ]
                },
                {
                    "type": "GENETIC",
                    "name": "High Dose LX2006",
                    "description": "Adeno-associated viral vector encoding the FXN gene (AAVrh.10hFXN)",
                    "armGroupLabels": [
                        "Cohort 1/ Cohort 2/ Cohort 3"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Treatment-emergent adverse events (TEAEs) and Treatment-emergent serious events (TESAEs)",
                    "timeFrame": "Change from baseline to end of year 5 post dose"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from baseline in LVMi",
                    "timeFrame": "Change from baseline to end of year 5 post dose"
                },
                {
                    "measure": "Change from baseline in LVEF",
                    "timeFrame": "Change from baseline to end of year 5 post dose"
                },
                {
                    "measure": "Change from baseline in cardiac fibrosis as measured by cardiac MRI",
                    "timeFrame": "Change from baseline to end of year 5 post dose"
                },
                {
                    "measure": "Change from baseline in measures of cardiopulmonary exercise tolerance",
                    "timeFrame": "Change from baseline to end of year 5 post dose"
                },
                {
                    "measure": "Presence and severity of cardiac arrythmias",
                    "timeFrame": "Change from baseline to end of year 5 post dose"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Confirmed genetic diagnosis of FA, with onset being before 25 years of age\n* Protocol specified ranges for antibodies\n* Protocol specified measures of FA cardiomyopathy\n\nExclusion Criteria:\n\n* Protocol specified ranges for left ventricular ejection fraction (LVEF) as measured by cardiac ECHO\n* Uncontrolled diabetes\n* Abnormal liver function\n* Active infection of any type, including hepatitis virus (A, B or C) or human immunodeficiency virus (HIV-1 and HIV-2)\n* Contraindication to cardiac MRI\n* Contraindications to cardiac biopsies\n* Participants who are receiving systemic corticosteroids or other immunosuppressive medications\n* History of significant coronary artery disease or any structural heart or vascular disease other than FA cardiomyopathy\n* Presence of clinically significant, hemodynamically unstable arrhythmias, requiring physician intervention\n* Presence of clinically significant abnormalities as determined by the investigator, other than ECG abnormalities related to FA\n* Uncontrolled psychiatric disease\n\nOther Inclusion/Exclusion criteria to be applied as per protocol.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "50 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "LEXEO Clinical Trials",
                    "role": "CONTACT",
                    "phone": "212-547-9879",
                    "email": "clinicaltrials@lexeotx.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "LEXEO Clinical Trials",
                    "affiliation": "Lexeo Therapeutics",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Ataxia Center and HD Center of Excellence, University of California",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Aaron Fisher",
                            "role": "CONTACT",
                            "phone": "310-206-8153",
                            "email": "adfisher@mednet.ucla.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of South Florida",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lucretia Campbell",
                            "role": "CONTACT",
                            "phone": "813-974-5633",
                            "email": "lcampbel@usf.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "University of Iowa",
                    "status": "WITHDRAWN",
                    "city": "Iowa City",
                    "state": "Iowa",
                    "zip": "52242",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.66113,
                        "lon": -91.53017
                    }
                },
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michaela Kolarova",
                            "role": "CONTACT",
                            "phone": "507-266-7969",
                            "email": "kolarova.michaela@mayo.edu"
                        },
                        {
                            "name": "Clinical Genomics Research Team",
                            "role": "CONTACT",
                            "email": "rstcgresearch@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "Hospital of the University of Pennsylvania",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "David Lynch, MD, PhD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Centre hospitalier de l Universite de Montreal (CHUM)",
                    "status": "WITHDRAWN",
                    "city": "Montr\u00e9al",
                    "state": "Quebec",
                    "zip": "H2X 0C1",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001259",
                    "term": "Ataxia"
                },
                {
                    "id": "D000002524",
                    "term": "Cerebellar Ataxia"
                },
                {
                    "id": "D000005621",
                    "term": "Friedreich Ataxia"
                },
                {
                    "id": "D000009202",
                    "term": "Cardiomyopathies"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000020820",
                    "term": "Dyskinesias"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000002526",
                    "term": "Cerebellar Diseases"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000013132",
                    "term": "Spinocerebellar Degenerations"
                },
                {
                    "id": "D000013118",
                    "term": "Spinal Cord Diseases"
                },
                {
                    "id": "D000020271",
                    "term": "Heredodegenerative Disorders, Nervous System"
                },
                {
                    "id": "D000019636",
                    "term": "Neurodegenerative Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000028361",
                    "term": "Mitochondrial Diseases"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4565",
                    "name": "Ataxia",
                    "asFound": "Ataxia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12307",
                    "name": "Neoplasm Metastasis",
                    "relevance": "LOW"
                },
                {
                    "id": "M12154",
                    "name": "Cardiomyopathies",
                    "asFound": "Cardiomyopathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8741",
                    "name": "Friedreich Ataxia",
                    "asFound": "Friedreich's Ataxia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5773",
                    "name": "Cerebellar Ataxia",
                    "asFound": "Ataxia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22574",
                    "name": "Dyskinesias",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M5775",
                    "name": "Cerebellar Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22510",
                    "name": "Spinocerebellar Ataxias",
                    "relevance": "LOW"
                },
                {
                    "id": "M15929",
                    "name": "Spinocerebellar Degenerations",
                    "relevance": "LOW"
                },
                {
                    "id": "M15915",
                    "name": "Spinal Cord Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22092",
                    "name": "Heredodegenerative Disorders, Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M21558",
                    "name": "Neurodegenerative Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M23341",
                    "name": "Mitochondrial Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2386",
                    "name": "Friedreich Ataxia",
                    "asFound": "Friedreich's Ataxia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5352",
                    "name": "Spinocerebellar Ataxia",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}